Could a Team-Based approach improve life for lung disease patients?
NCT ID NCT06626438
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether a personalized 'treatable traits' care model—where patients see a lung specialist, physiotherapist, psychologist, and dietitian together—can improve quality of life and slow disease progression in people with interstitial lung disease. About 110 participants will be randomly assigned to either this team-based care or standard care. The study measures quality of life, symptoms, exercise capacity, and survival without progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- treatable traits model of care (multidisciplinary clinic with doctor, physiotherapist, psychologist, dietitian)
- What this could lead to
- If it works, this could show that personalized, team-based care improves quality of life and slows disease progression for people with interstitial lung disease.
- What could go wrong
- This is a relatively small, early-stage trial testing a care model rather than a drug, so results may not be dramatic or widely applicable. The intervention is complex and may not be easy to implement in other settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASES (ILD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fiona Stanley Hospital
RECRUITINGPerth, Western Australia, 6150, Australia
-
Sir Charles Gairdner Hospital
NOT_YET_RECRUITINGPerth, Western Australia, 6009, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.